FRA:7XE (Finland)
Â
Ordinary Shares - Series B
€
2.91
-0.13 (-4.28%)
Apr 4
Warning! GuruFocus detected
4 Severe warning signs
with 7XE.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Nightingale Health PLC
ISIN : FI4000490875
Share Class Description:
FRA:7XE: Ordinary Shares - Series BCompare
Compare
Traded in other countries / regions
HEALTH.Finland7XE.GermanyNGHLF.USA IPO Date
2021-03-26Description
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 35.14 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 11.32 | |||||
| Beneish M-Score | -1.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.7 | |||||
| 3-Year EBITDA Growth Rate | -10 | |||||
| 3-Year EPS without NRI Growth Rate | -32 | |||||
| 3-Year FCF Growth Rate | -35.2 | |||||
| 3-Year Book Growth Rate | -12.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 8.66 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 45.48 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.87 | |||||
| 9-Day RSI | 42.48 | |||||
| 14-Day RSI | 47.27 | |||||
| 3-1 Month Momentum % | -12.67 | |||||
| 6-1 Month Momentum % | -16.83 | |||||
| 12-1 Month Momentum % | 150.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.46 | |||||
| Quick Ratio | 12.21 | |||||
| Cash Ratio | 11.99 | |||||
| Days Inventory | 219.14 | |||||
| Days Sales Outstanding | 65.98 | |||||
| Days Payable | 564.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 1.33 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.77 | |||||
| Operating Margin % | -373.12 | |||||
| Net Margin % | -346.11 | |||||
| FCF Margin % | -244.94 | |||||
| ROE % | -20.66 | |||||
| ROA % | -19.12 | |||||
| ROIC % | -77.12 | |||||
| 3-Year ROIIC % | 157.41 | |||||
| ROC (Joel Greenblatt) % | -211.84 | |||||
| ROCE % | -19.95 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 32.2 | |||||
| PB Ratio | 2.11 | |||||
| Price-to-Tangible-Book | 2.47 | |||||
| EV-to-EBIT | -6.05 | |||||
| EV-to-EBITDA | -12.44 | |||||
| EV-to-Revenue | 20.46 | |||||
| EV-to-FCF | -8.35 | |||||
| Price-to-GF-Value | 1.09 | |||||
| Price-to-Net-Current-Asset-Value | 2.8 | |||||
| Price-to-Net-Cash | 2.94 | |||||
| Earnings Yield (Greenblatt) % | -16.53 | |||||
| FCF Yield % | -7.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nightingale Health PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.951 | ||
| EPS (TTM) (€) | -0.29 | ||
| Beta | 0.73 | ||
| 3-Year Sharpe Ratio | 0.43 | ||
| 3-Year Sortino Ratio | 1.07 | ||
| Volatility % | 124.96 | ||
| 14-Day RSI | 47.27 | ||
| 14-Day ATR (€) | 0.096133 | ||
| 20-Day SMA (€) | 3.0255 | ||
| 12-1 Month Momentum % | 150.72 | ||
| 52-Week Range (€) | 1.01 - 4.19 | ||
| Shares Outstanding (Mil) | 60.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nightingale Health PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nightingale Health PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nightingale Health PLC Frequently Asked Questions
What is Nightingale Health PLC(FRA:7XE)'s stock price today?
The current price of FRA:7XE is €2.91. The 52 week high of FRA:7XE is €4.19 and 52 week low is €1.01.
When is next earnings date of Nightingale Health PLC(FRA:7XE)?
The next earnings date of Nightingale Health PLC(FRA:7XE) is 2025-09-19 Est..
Does Nightingale Health PLC(FRA:7XE) pay dividends? If so, how much?
Nightingale Health PLC(FRA:7XE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers